11/25/2024 Motion to extend the time to file a response from December 13, 2024 to February 11, 2025, submitted to The Clerk. 11/27/2024 Motion to extend the time to file a response is granted in part, ...

Takeda is tapping out of the cell therapy arena as part of a "strategic portfolio reprioritization," with 137 roles at the drugmaker's Massachusetts R&D site affected. The company is seeking a partner ...

Takeda will abandon all of its cell therapy work, retreating from research into a field it had made once made a strategic priority. The Japanese pharmaceutical giant said on Wednesday that, as part of ...

Therapists treating Medicaid enrollees in Colorado will have to get the state’s authorization to conduct more than 24 sessions with an individual patient in a year, as the department overseeing the ...

Have you noticed you're sleeping a little longer? Maybe you're experiencing a shift in appetite — craving more sweets or pasta. In autumn, our bodies sense the change in light as the dark winter ...

What is thyroid hormone replacement therapy? Thyroid hormone therapy is the use of manmade thyroid hormones to raise abnormally low levels of natural thyroid hormones in the body. Thyroid hormone is ...

Notre Dame wide receivers Jaden Greathouse (left) and Will Pauling (right). (Photos by Mike Miller/BGI) Notre Dame has two good options to start in the slot in Jaden Greathouse and Will Pauling. So, ...

Simply search “Red Light Therapy” on your favourite social media platform and behold the misinformation. If you’ve been on social media, you’ve probably seen ads for red light therapy — glowing panels ...

Researchers in the United Kingdom say they have successfully trialed what could become the world's first gene therapy for Huntington's disease – a fatal neurodegenerative disorder that is typically ...

Researchers in the UK say clinical trials conducted on a small number of people show that a new gene therapy has slowed the progression of Huntington's disease, a fatal neurological condition. The ...

UniQure has set its sights on submitting its Huntington’s disease gene therapy for approval next year after the asset was shown to slow progression of the neurodegenerative condition by 75% in a phase ...